MARINE BIOLOGICAL LABORATORY
MARINE BIOLOGICAL LABORATORY
MARINE BIOLOGICAL LABORATORY
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$245,049,089
Investments
48%
Property, Plant, & Equipment (net)
44%
Receivables (Non-Related)
4%
Other Assets
2%
Cash & Equivalents
2%
Prepaid Expenses
<1%
Inventories
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$35,380,429
Tax-Exempt Bond Liabilities
59%
Deferred Revenue
23%
Payables & Accruals
16%
Other Liabilities
2%
Grants Payable
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,508,009
$4,537,321
+29%
Receivables (Non-Related)
$12,937,572
$9,162,189
-29%
Related-Party Receivables
$0
$0
-
Inventories
$106,378
$111,657
+5%
Prepaid Expenses
$1,002,875
$776,589
-23%
Investments
$112,849,859
$116,568,886
+3%
Property, Plant, & Equipment (net)
$104,298,188
$108,245,808
+4%
Other Assets
$4,025,044
$5,646,639
+40%
Total Assets
$238,727,925
$245,049,089
+3%
Liabilities
2023
2024
Change
Payables & Accruals
$5,072,199
$5,622,417
+11%
Grants Payable
$0
$0
-
Deferred Revenue
$7,455,048
$8,058,000
+8%
Tax-Exempt Bond Liabilities
$21,899,513
$20,887,629
-5%
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$1,140,224
$812,383
-29%
Total Liabilities
$35,566,984
$35,380,429
-1%
Net assets
2023
2024
Change
Restricted Net Assets
$105,992,706
$107,122,172
+1%
Unrestricted Net Assets
$97,168,235
$102,546,488
+6%
Net assets
2023
2024
Change
Net assets
+$203,160,941
+$209,668,660
+3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)